Pelvic organ prolapse in women with autosomal dominant polycystic kidney disease under tolvaptan treatment

Nefrologia (Engl Ed). 2023 Nov-Dec;43(6):791-792. doi: 10.1016/j.nefroe.2021.09.011. Epub 2023 Oct 23.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antidiuretic Hormone Receptor Antagonists / therapeutic use
  • Female
  • Glomerular Filtration Rate
  • Humans
  • Pelvic Organ Prolapse*
  • Polycystic Kidney, Autosomal Dominant* / complications
  • Polycystic Kidney, Autosomal Dominant* / drug therapy
  • Tolvaptan / therapeutic use

Substances

  • Tolvaptan
  • Antidiuretic Hormone Receptor Antagonists